Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Affiliate Scientist, McEwen Stem Cell InstituteAssistant Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
Dr. Shinichiro Ogawa joined the McEwen Stem Cell Institute in 2019 as a Principal Investigator. His research program is focused on developing cell- and tissue-based replacement therapies that can provide an alternative therapy to liver transplant for patients with liver failure.
Dr. Ogawa completed his PhD at Shinshu University School of Medicine in Nagano, Japan and his MD at the Tokyo Medical University in Tokyo, Japan. He completed a post-doctoral fellowship in the laboratory of Dr. Gordon Keller at the McEwen Centre for Regenerative Medicine prior to his appointment. Dr. Ogawa also holds an appointment as Professor at the Department of Surgery at Shinshu University School of Medicine in Japan.
In his research, he has developed methods to use hPSCs to generate liver progenitors (hepatoblasts), which can generate functional liver cells. He has used these progenitors to develop mature liver cells and bile duct epithelial cells, both of which have the characteristic properties of functional cells in the liver. In his work with the McEwen Stem Cell Institute, Dr. Ogawa is using hPSC-derived liver cells and organoids to assess restoration of liver function in an experimental model with the goal of developing treatments for liver failure. He is also using hPSC-derived bile duct epithelial cells to develop models to study Cystic Fibrosis Liver Disease and screen drugs for treatment.
Generation of functional ciliated cholangiocytes from human pluripotent stem cellsNature Communications. 2021 Nov 11;12(1):6504Ogawa M, Jiang J-X, Xia S, Yang D, Ding A, Laselva O, Chin S, Hernandez M, Cui C, Higuchi Y, Suemizu H, Dorrell C, Grompe M, Bear CE, Keller G, Ogawa S. Nat Commun.
Directed differentiation of cholangiocytes from human pluripotent stem cellsNature Biotechnology. 2015 Aug;33(8):853-61Ogawa M, Ogawa S, Bear CE, Ahmadi S, Chin S, Li B, Grompe M, Keller G, Kamath BM, Ghanekar A.
Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytesDevelopment. 2013 Aug;140(15):3285-96.Ogawa S, Surapisitchat J, Virtanen C, Ogawa M, Niapour M, Sugamori KS, Wang S, Tamblyn L, Guillemette C, Hoffmann E, Zhao B, Strom S, Laposa RR, Tyndale RF, Grant DM, Keller G.
Principal Investigator: Dr. Shinichiro Ogawa
Administrative Assistant: Jonelle Martineau
Lab Manager: Dr. Mina Ogawa